Steven De Jonghe
Rega Institute for Medical Research(BE)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Biochemical and Molecular Research, HIV/AIDS drug development and treatment, COVID-19 Clinical Research Studies, Computational Drug Discovery Methods
Most-Cited Works
- → Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern(2022)429 cited
- → Ultralarge Virtual Screening Identifies SARS-CoV-2 Main Protease Inhibitors with Broad-Spectrum Activity against Coronaviruses(2022)239 cited
- → Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects(2017)233 cited
- → The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir(2023)164 cited
- → Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors(2023)163 cited
- → Identification of Inhibitors of SARS-CoV-2 3CL-Pro Enzymatic Activity Using a Small Molecule in Vitro Repurposing Screen(2021)155 cited
- → The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model(2021)143 cited
- → Molnupiravir Inhibits Replication of the Emerging SARS-CoV-2 Variants of Concern in a Hamster Infection Model(2021)132 cited
- → The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern(2022)132 cited
- → Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19(2021)97 cited